FDA Inspection 1316050 — Dr. Manik Changoji Bhise, M.D.
The FDA completed an inspection of Dr. Manik Changoji Bhise, M.D. on April 30, 2026 in Aurangabad. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- April 30, 2026
- Fiscal Year
- 2026
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Aurangabad (India)
Additional Details
Clinical BA/BE